The biopharmaceutical industry will continue to be the most important industry in the 21st century, displaying key characteristics such as high product value, large investments, long production cycles, high profits but also high risks. Whether producing vaccines, antibodies, insulin, blood products, nucleic acid drugs or other biopharmaceuticals, manufacturers must always work to reduce investment, shorten the time to product launch, and ensure safe production. Through process upgrading, production scheduling and plant layout optimization, Morimatsu can help clients achieve efficient and reliable production processes.
Our team members have extensive international experiences in biopharmaceutical production, design, processing technology etc and which are technologically advanced and regulatory compliant. Our project managers, design team and validation experts are experienced senior professionals from Sweden, the United States, Italy, Japan, India and China. Their professional fields include process engineering, automation, mechanical-, electrical-, architectural and structural engineering, validation, regulatory requirements, project management.
Based on the deep understanding of product process and accurate interpretation of industrialy regulations, Morimatsu can provide integrated digital-intellectualized engineering solutions including core machines, value-added services and modular plants for the R & D pilot and commercial production biopharma industry. Morimatsu's unique life-cycle services cover front-end services such as joint R & D process scale-up, feasibility study, basic design, concept design, and digitized-top-level design, as well as back-end services after delivery such as product manufacturing, digital operation and maintenance, validation, so as to better help bio-pharmaceutical companies to quickly realize process transfer, process scale-up, and industrial production.
As a total solution provider of plant + overall upstream and downstream process system, we help customers to reduce the communication interface, improve the controllability and efficiency of project execution, while at the same time, minimize the project risks and accelerate the speed of product to market via our modular project delivery.